Related Experiment Video
Updated: Apr 23, 2026

11:22
Investigations on the GaIII Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue
Published on: August 17, 2016
9.3K
Re and (99m)Tc complexes of BodP3--multi-modality imaging probes
Laura H Davies1, Benjamin B Kasten, Paul D Benny
1School of Chemistry, Newcastle University, Bedson Building, Newcastle upon Tyne, NE1 7RU, UK. lee.higham@ncl.ac.uk.
Summary
A novel fluorescent phosphine, BodP3, forms rhenium complexes for effective cancer cell imaging. Technetium analogues offer potential as dual SPECT/fluorescent biological probes.
Area of Science:
- Radiochemistry
- Chemical Biology
- Molecular Imaging
Background:
- Development of novel imaging agents is crucial for early cancer detection.
- Fluorescent and SPECT probes offer complementary detection modalities.
- Tridentate phosphine ligands can form stable metal complexes for biomedical applications.
Purpose of the Study:
- To synthesize and characterize rhenium complexes with a fluorescent tridentate phosphine, BodP3.
- To evaluate the potential of these complexes for cancer cell imaging.
- To explore the preparation and utility of technetium analogues as dual-modality probes.
Main Methods:
- Synthesis of the fluorescent tridentate phosphine ligand BodP3.
- Complexation of BodP3 with rhenium and technetium isotopes.
- Fluorescence microscopy for cellular imaging.
- SPECT imaging studies (in vitro/in vivo).
Main Results:
- BodP3 successfully formed stable rhenium complexes.
- These rhenium complexes demonstrated effective fluorescence imaging of cancer cells.
- Technetium analogues were readily prepared and exhibited dual SPECT/fluorescent properties.
Conclusions:
- BodP3-based rhenium complexes are promising fluorescent agents for cancer cell imaging.
- Technetium analogues of BodP3 complexes hold potential as versatile dual-modality biological probes.
- This work expands the toolkit for molecular imaging in oncology.
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
842
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
842
Positron Emission Tomography
6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K

